In Vitro: Dihexa binds with high affinity to HGF and both dihexa and its parent compound Norleucine 1-AngIV induce c-Met phosphorylation in the presence of subthreshold concentrations of HGF and augment HGF-dependent cell scattering. Further, dihexa and Nle1-AngIV induce hippocampal spinogenesis and synaptogenesis similar to HGF itself. Dihexa effectively inhibits HGF dimerization at 1 M. While dihexa at 1 nM and 10 pM alone does not activate c-Met, it markedly augments the capacity of HGF at 1.25 and 2.5 ng/mL to activate c-Met
Our Peptide Therapy Program Focus Areas Recovery & Repair Muscle and tissue recovery Joint and connective tissue support Gut lining and tissue integrity Energy & Metabolic Support Energy levels and stamina Metabolic efficiency Body composition goals Skin, Hair & Collagen Health Skin quality and elasticity Hair and scalp health Cellular renewal and collagen production Longevity & Performance Healthy aging Physical resilience Long-term vitality and performance This treatment may not be suitable for individuals who are pregnant, breastfeeding, or have certain medical conditions
Subcutaneous dosages of Compounded Semaglutide typically start at 0.25 mg per week for the first four weeks as the body adjusts, then increase to 0.5 mg weekly from the fifth week onwards
By reducing oxidative damage, L-Carnitine may support neuroprotection
Always follow the instructions and do the testing accordingly
Professional oversight isnt optional here
